Diabetes type 2. Type 2 diabetes mellitus
Conditions
Interventions
Intervention group: type 2 diabetic patients resistant to other oral anti-diabetic treatments (metformin, glybenclamide and acarbose) whose FBS and HbA1C are not within the therapeutic range despite r
Sponsors
Arak University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: patients who have been diagnosed with type 2 diabetes mellitus based on the ADA diagnostic criteria and indicated for medical therapy patients who have not reached to treatment goals despite receiving previous medications
Exclusion criteria
Exclusion criteria: type 1 diabetes pregnancy diabetic ketoacidosis (present and previous) pancreatitis (present and previous) diabetic foot ulcer (present and previous) GFR less than 30 BMI less than 18.5 severe adverse drug reactions lack of consent to participate in the study untreated urinary tract infection
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fasting blood sugar. Timepoint: beginning of the study, 3 months later. Method of measurement: blood sample. | — |
Secondary
| Measure | Time frame |
|---|---|
| Glycosylated hemoglobin. Timepoint: beginning of the study, 3 months later. Method of measurement: blood sample. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohammad Davari
Arak University of Medical Sciences
Outcome results
None listed